ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19 Posted on October 7, 2020 by ARCA IT - Press Release, Uncategorized 10.07-AB201-COVID-IND-Approval-Study-May-Proceed-FINAL
ARCA biopharma Announces Promotion of Chief Medical Officer and Vice President, Regulatory Affairs & Quality Posted on October 5, 2020 by ARCA IT - Press Release, Uncategorized 10.5-Management-Promotions
ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19 Posted on September 21, 2020 by ARCA IT - Press Release, Uncategorized 9.21-AB201-COVID-IND-Submission
ARCA BIOPHARMA ANNOUNCES COMPLETION OF FDA PRE-IND CONSULTATION UNDER CORONAVIRUS TREATMENT ACCELERATION PROGRAM FOR AB201 AS A POTENTIAL TREATMENT FOR SEVERE COVID-19 Posted on August 12, 2020 by ARCA IT - Press Release, Uncategorized AB201-COVID-Pre-IND-Completed
ARCA BIOPHARMA ANNOUNCES SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Posted on August 5, 2020 by ARCA IT - Press Release, Uncategorized ARCA-2Q20-Financial-Results-and-Business-Update
SARS-CoV-2 Cell Entry Mechanisms in Intact Human Heart Published in JACC: Basic to Translational Science by University of Colorado Anschutz Medical Campus and ARCA biopharma Investigators Posted on July 7, 2020 by ARCA IT - Press Release, Uncategorized ARCA-UC-COVID-19-CV-Paper-Published-JACC-JBTS
ARCA BIOPHARMA ANNOUNCES CLOSING OF $6.1 MILLION REGISTERED DIRECT OFFERING Posted on June 3, 2020 by ARCA IT - Press Release, Uncategorized ARCA-Registered-Direct-Offering-Closing
ARCA BIOPHARMA ANNOUNCES $9.4 MILLION REGISTERED DIRECT OFFERING Posted on June 1, 2020 by ARCA IT - Press Release, Uncategorized ARCA-Registered-Direct-Offering
ARCA BIOPHARMA ANNOUNCES AB201 DEVELOPMENT PROGRAM FOR TREATMENT OF COVID-19 ASSOCIATED COAGULOPATHY Posted on May 28, 2020 by ARCA IT - Press Release, Uncategorized AB201-Development-for-COVID-19-FINAL
CLINICAL DATA EVALUATING GENCARO FOR THE TREATMENT OF ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS FEATURED IN THREE PRESENTATIONS AT THE 2020 HEART RHYTHM SCIENTIFIC SESSIONS Posted on May 7, 2020 by ARCA IT - Press Release, Uncategorized Gencaro-Data-at-HRS-2020